Print  Close

Cortical Inhibition Drives iTBS Efficacy in Treatment-Resistant Depression

Davide Momi Presenter
Stanford University
Stanford, CA 
United States
 
Friday, Jun 27: 11:30 AM - 11:42 AM
1274 
Oral Sessions 
Brisbane Convention & Exhibition Centre 
Room: Great Hall (Mezzanine Level) Doors 5, 6 & 7 
Depression remains a significant global health challenge, with Intermittent Theta Burst Stimulation (iTBS) targeting the left dorsolateral prefrontal cortex (DLPFC) as a promising intervention for treatment-resistant depression. However, the neurophysiological mechanisms driving its clinical efficacy are not fully understood.